Related references
Note: Only part of the references are listed.ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2
Sung O. Park et al.
BLOOD (2008)
Bone morphogenetic protein-9 is a circulating vascular quiescence factor
Laurent David et al.
CIRCULATION RESEARCH (2008)
Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue
Anastasia Sobolewski et al.
HUMAN MOLECULAR GENETICS (2008)
Endoglin Promotes Transforming Growth Factor β-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC
Nam Y. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Functional characterization of bone morphogenetic protein binding sites and smad1/5 activation in human vascular cells
Paul D. Upton et al.
MOLECULAR PHARMACOLOGY (2008)
BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis
Marion Scharpfenecker et al.
JOURNAL OF CELL SCIENCE (2007)
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells
Laurent David et al.
BLOOD (2007)
Pathology of pulmonary hypertension
Rubin M. Tuder et al.
CLINICS IN CHEST MEDICINE (2007)
SMAD4 mutations found in unselected HHT patients
C. J. Gallione et al.
JOURNAL OF MEDICAL GENETICS (2006)
Hereditary hemorrhagic telangiectasia:: an update on clinical manifestations and diagnostic measures
H Sadick et al.
WIENER KLINISCHE WOCHENSCHRIFT (2006)
Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development
T Seki et al.
LABORATORY INVESTIGATION (2006)
Mutations of the TGF-β type II receptor BMPR2 in pulmonary arterial hypertension
RD Machado et al.
HUMAN MUTATION (2006)
Blood outgrowth endothelial cells from hereditary haemorrhagic telangiectasia patients reveal abnormalities compatible with vascular lesions
A Fernandez-L et al.
CARDIOVASCULAR RESEARCH (2005)
Role of IL-6 in systemic angiogenesis of the lung
JY McClintock et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor β1 with higher affinity receptors and an activated Alk1 pathway
N Pece-Barbara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia
V Cottin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telanglectasia associated with mutations in MADH4 (SMAD4)
CJ Gallione et al.
LANCET (2004)
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia
SA Abdalla et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
M Uhl et al.
CANCER RESEARCH (2004)
The survival effect of TNF-α in human neutrophils is mediated via NF-κB-dependent IL-8 release
AS Cowburn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
E-selectin is required for the antiangiogenic activity of endostatin
Y Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia
RE Harrison et al.
JOURNAL OF MEDICAL GENETICS (2003)
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFP/ALK5 signaling
MJ Goumans et al.
MOLECULAR CELL (2003)
Hereditary hemorrhagic telangiectasia:: an update on transforming growth factor β signaling in vasculogenesis and angiogenesis
S van den Driesche et al.
CARDIOVASCULAR RESEARCH (2003)
Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis
S Lamouille et al.
BLOOD (2002)
Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells
G Valdimarsdottir et al.
CIRCULATION (2002)
Balancing the activation state of the endothelium via two distinct TGF-β type I receptors
MJ Goumans et al.
EMBO JOURNAL (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Altered growth responses of muscle cells from patients pulmonary artery smooth with primary pulmonary hypertension to transforming growth factor-β1 and bone morphogenetic proteins
NW Morrell et al.
CIRCULATION (2001)
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
RC Trembath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Smad3/AP-1 interactions control transcriptional responses to TGF-β in a promoter-specific manner
F Verrecchia et al.
ONCOGENE (2001)
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
ZM Deng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)
Cell-cell interactions in synovitis - Endothelial cells and immune cell migration
Z Szekanecz et al.
ARTHRITIS RESEARCH (2000)
Share Paper
